Search

MSK studies look at the role of RNA splicing factors in acute myeloid leukemia and melanoma.

… Wednesday, October 9, 2019 Summary Two studies looked at the role of specific RNA splicing factors in different cancers. These factors help regulate how proteins are manufactured. Manufacturing proteins is a multistep process that’s hard-coded into how our cells operate. Genes, which are made of DNA,

Along with defending against pathogens, the body’s innate immune system helps to protect the stability of our genomes in unexpected ways — ways that have important implications for the development of cancer, researchers at MSK are discovering.

… Tuesday, November 5, 2024 Along with defending against pathogens, the body’s innate immune system helps to protect the stability of our genomes in unexpected ways — ways that have important implications for the development of cancer, researchers at Memorial Sloan Kettering Cancer Center (MSK) are discovering

MSK is proud to return as a participant in the 4th Annual Black Health Matters Virtual Summit. Black Health Matters Virtual Summit will provide attendees a chance to interact with physicians, scientists, and advocates, including former First Lady, Michelle Obama, to address equity in all areas of health.

… Wednesday, July 15, 2020 Memorial Sloan Kettering Cancer Center (MSK) is proud to return as a participant in the 4 th Annual Black Health Matters Virtual Summit on Saturday, July 18, from 8:30 a.m. to 6:00 p.m. COVID-19 has created new and unprecedented challenges for patients. This year’s virtual event

MSK is a founding member of the Cancer AI Alliance (CAIA), an exciting collaborative research initiative designed to accelerate development and deployment of AI models to improve cancer care. This unique alliance unites four leading NCI-designated cancer centers — MSK, Dana-Farber Cancer Institute, Fred Hutch Cancer Center, and The Sidney Kimmel Comprehensive Cancer Center and Whiting School of Engineering at Johns Hopkins — with technology powerhouses that include Ai2, Amazon, Deloitte, Google, Microsoft, Nvidia, and Slalom.

… Wednesday, December 24, 2025 MSK is a founding member of the  Cancer AI Alliance (CAIA) , an exciting collaborative research initiative designed to accelerate development and deployment of AI models to improve cancer care.   This unique alliance unites four leading NCI-designated cancer centers — MSK

Learn how MSK experts are improving the detection and treatment of lung cancer, from fundamental questions of the disease biology to new screening and therapy options.

… Friday, June 6, 2025 Jen Cosgrove says her first appointment at Memorial Sloan Kettering Cancer Cen­ter (MSK) was unforgettable. “When my family and I showed up at MSK, we felt totally defeated,” she says. “We knew I had a type of lung cancer called adenocarcinoma — that was it.” As a wife and mother

May is Clinical Trials Awareness Month, culminating on May 20 with International Clinical Trials Day. For institutions like ours, this is an opportunity to commemorate the importance of clinical research and the valued contributions of clinical research professionals around the world.

… Friday, October 3, 2025 May is Clinical Trials Awareness Month, culminating on May 20 with International Clinical Trials Day. For institutions like ours, this is an opportunity to commemorate the importance of clinical research and the valued contributions of clinical research professionals around the

MSK research provides a clearer understanding of glioblastoma heterogeneity to aid development of new therapies; sheds light on mechanisms of cellular plasticity; presents a new imaging technique that could improve the diagnosis of brain diseases by revealing how different parts of the brain are metabolizing nutrients; describes a new method to aid the study of rare but influential cell populations; and identifies a potential treatment for malignant peripheral nerve sheath tumors.

… Friday, January 17, 2025 New research from Memorial Sloan Kettering Cancer Center (MSK) provides a clearer understanding of glioblastoma heterogeneity to aid development of new therapies; sheds light on mechanisms of cellular plasticity; presents a new imaging technique that could improve the diagnosis

Hedvig Hricak, Chair of Memorial Sloan Kettering's Department of Radiology and incumbent of the Carroll and Milton Petrie Chair, has been named the 95th President of the Radiological Society of North America Board of Directors.

… Monday, February 1, 2010 Summary Hedvig Hricak, Chair of Memorial Sloan Kettering’s Department of Radiology and incumbent of the Carroll and Milton Petrie Chair, has been named the 95th President of the Radiological Society of North America Board of Directors. Hedvig Hricak , Chair of Memorial Sloan

About two dozen MSK physicians and researchers shared their work at the world’s leading breast cancer conference, held annually in San Antonio.

… Friday, December 13, 2019 At the annual San Antonio Breast Cancer Symposium, MSK investigators presented the latest research on detection and screening methods for people at high risk; immunotherapy for breast cancer; and the underlying causes of resistance to targeted therapies, among other topics.

Memorial Sloan Kettering Cancer Center (MSK) issued the following statement regarding its financial results for the first two quarters of 2025:

… Friday, August 15, 2025 Memorial Sloan Kettering Cancer Center (MSK) issued the following statement regarding its financial results for the first two quarters of 2025:  MSK’s financial performance for the first half of 2025 resulted in a deficiency of operating revenues over expenses of $(113.2) million